Company: HCWB
Filing Date: 2025-05-09
Form Type: S-1
Source: 0001193125-25-116745
Chunk: 15

Company: HCW Biologics Inc.
Filing Date: 2025-05-09
Form: S-1
Chunk 15
---
 to up to 9.99%) of the Common Stock outstanding immediately after giving effect 
 to such exercise. Each Pre-Funded Warrant will be exercisable for one share of Common Stock. The purchase price of each Unit including a Pre-Funded Warrant (and accompanying Common Stock Warrant) will be equal to the price per Unit including one     
 share of Common Stock, minus $0.0001, and the exercise price of each Pre-Funded Warrant will equal $0.0001 per share. The Pre-Funded Warrants will be immediately exercisable (subject to the beneficial ownership cap) and may be exercised at any time  
 in perpetuity or until all of the Pre-Funded Warrants are exercised in full. This offering also relates to the shares of Common Stock issuable upon the exercise of the Pre-Funded Warrants.                                                              |
|                                             |     | The Units will not be certificated or issued in stand-alone form. The shares of our Common Stock (or Pre-Funded Warrants) and the Common Stock Warrants comprising the Units are immediately separable upon issuance and will be issued                   
 separately in this offering.                                                                                                                                                                                                                              |
|                                             |     | The Common Stock Warrants will have an exercise price per share of 100% of the public offering price per Unit, will be exercisable immediately and will expire on the fifth anniversary of the original issuance date. Each warrant is                    
 exercisable for one share of Common Stock, subject to adjustment in the event of stock dividends, stock splits, stock combinations, reclassifications, reorganizations or similar events affecting our Common Stock as described herein. Each holder of   
 Common Stock Warrants will be prohibited from exercising its warrant for shares of our Common Stock if, as a result of such exercise, the holder, together with its affiliates, would own more than 4.99% of the total number of shares of our Common     
 Stock then issued and outstanding. However, any holder may increase such percentage to any other percentage not in excess of 9.99%. This offering also relates to the offering of the shares of Common Stock issuable upon the exercise of the Common     
 Stock Warrants. For more information regarding the warrants, you should carefully read the section titled “Description of Securities — Warrants” in this prospectus.                                                                                      |
| Shares of Common Stock being offered by us: |     | Up to 655,308 shares of Common Stock (assuming the sale of the maximum number of Units covered by this prospectus, no issuance of